… with cannabinoids had a diagnosis of FM (42). In 2008, a randomised double-blind
placebo-controlled study evaluated the effectiveness of nabilone, a cannabinoid commercialised in …

… Cannabinoids apparently act on inflammation through mechanisms different fromthose of
agents such as nonsteroidal anti‐inflammatory drugs (NSAIDs). As a class, the cannabinoids …

… of cannabinoids and the endocannabinoid system has greatly advanced. With expanding
knowledge, synthetic cannabinoids – … This article reviews cannabinoid agonists in general and …

Background In the absence of an ideal treatment for chronic pain associated with rheumatic
diseases, there is interest in the potential effects of cannabinoid molecules, particularly in …

… focused on patients those diagnosed with fibromyalgia who had been using licensed …
This study’s successful first assessment of the impact of medical cannabis con fibromyalgia …

… prescribed cannabinoids (eg, nabilone) are not mentioned in the Quebec algorithm. Citation2
The Canadian guidelines Citation8 suggest that a trial of prescribed cannabinoid could be …

… The efficacy of cannabinoids has been reported to be controversial in the literature when …
pain and fibromyalgia by means of a standardized retrospective telephone interview survey. …

… Only 18.1% were still using cannabinoids at 1 year with a median use of 31 days. Of these,
1894 patients had an underlying diagnosis of fibromyalgia, which was also identified as a …

Fibromyalgia (FM) is a common chronic pain condition, with prevalence rates between 2 and
8%. Characterized by widespread pain and associated symptoms such as fatigue, sleep …

… that synthetic cannabinoids might be an effective therapy in patients with fibromyalgia. …
to this challenging pain disorder, and therapeutic possibilities with synthetic cannabinoids. …